Table 3.
Viral load and physical status in cases with HR-HPV-positive status and p16 overexpression
| Case # | Age (y) | Sex | PCR | DNA ISH | Viral load (copies/ng DNA) | Integration | TN | Prognosis |
|---|---|---|---|---|---|---|---|---|
| 1 | 41 | M | HPV-16 | + | 77,735.0 | Mixed | T4aN2c | Alive w/o disease,84 mo |
| 2 | 41 | M | HPV-16 | NA | 34,671.6 | Mixed | T1bN0 | Alive w/o disease 34 mo |
| 3 | 78 | M | HPV-16 | NA | 58.4 | Mixed | T3 N1 | Alive w/o disease 15 mo |
| 4 | 58 | M | – | + | NA | NA | T1bN0 | Alive w/o disease 60 mo |
| 5 | 59 | M | – | + | NA | NA | T1aN0 | Alive w/o disease 29 mo |
#, number; y, years; NA, not available; TN, cT stage and cN stage; mo, months; w/o, without